InvestSMART

Total Brain Limited (ASX: TTB) - Share Price

DELISTED - Current share price for TTB : $0.002

TTB General Information +

ASX Code TTB
Website N/A
Industry/Sector Health Care Services
Market Cap ($M) n/a
TTB Share Price $0.002
Day High $0.002
Day Low $0.002
Last Close $0.002
TTB Share Price Movement - ( No change )
Prices as at 16:36, 2 Mar 2023
+Security prices are delayed by at least 20 minutes and are indicative only.

Total Brain Limited (TTB) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield

See all dividends from Total Brain Limited (TTB) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Total Brain Limited (TTB) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
Total Brain Limited (TTB)
ORDINARY FULLY PAID
 Health Care - Removal from Official List (COB 1 March 2023) 1 Mar 2023 10:24AM $0.002 $0.002 fallen by 0%
Total Brain Limited (TTB)
ORDINARY FULLY PAID
 Health Care - Suspension from Official Quotation 28 Feb 2023 7:00PM $0.002 $0.002 fallen by 0%
Total Brain Limited (TTB)
ORDINARY FULLY PAID
 Health Care - Appendix 4D and Half Year Report ended 31 December 2022 28 Feb 2023 4:11PM $0.002 $0.002 fallen by 0%
Total Brain Limited (TTB)
ORDINARY FULLY PAID
 Health Care - Notification of cessation of securities - TTB 27 Feb 2023 6:04PM $0.002 $0.002 fallen by 0%
Total Brain Limited (TTB)
ORDINARY FULLY PAID
 Health Care - Voluntary De-listing from ASX effective 1 March 2023 14 Feb 2023 8:52AM $0.007 $0.002 fallen by 71.43%
Total Brain Limited (TTB)
ORDINARY FULLY PAID
 Health Care - Notice of Extraordinary General Meeting/Proxy Form 9 Feb 2023 8:33AM $0.005 $0.002 fallen by 60%

TTB Directors

Name Position Start Date
Dr Evian Gordon Executive Chairman, Executive Director 8 Aug 2000
Mr Matthew (Matt) Morgan Non-Executive Director 1 Mar 2016
Mr David Torrible Non-Executive Director 1 Jun 2019

Total Brain Limited (TTB) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
19 Aug 2021 TORRIBLE, David Issued Indirect Shares 1,315,528 $0.260 $342,037.280
19 Aug 2021 GAGNON, Louis Issued Direct Shares 203,795 $0.260 $52,986.700
19 Aug 2021 MORGAN, Matthew (Matt) Issued Indirect Shares 64,246 $0.260 $16,703.960

See all changes in directors' interest & trades for Total Brain Limited (TTB) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

TTB Management

Name Position
Matthew Mund Chief Operating Officer
Matt Mund Chief Operating Officer,Interim CEO
Phillip Hains Joint Company Secretary
Nathan Kim -liung Jong Joint Company Secretary

TTB Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in -- (TTB). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
21,842,679 (16.33%) Zoltan Varga
8,403,529 (6.28%) David Daglio
7,370,793 (5.51%) David Torrible
6,992,500 (5.23%) Sun Hung Kai Global Opportunities Fund

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.